SomnoMed Limited
SOMNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $135,765 | $33,161 | $34,442 | $69,138 |
| - Cash | $17,293 | $18,498 | $16,179 | $12,838 |
| + Debt | $8,026 | $5,910 | $6,720 | $18,538 |
| Enterprise Value | $126,498 | $20,573 | $24,983 | $74,838 |
| Revenue | $57,784 | $53,709 | $46,537 | $45,115 |
| % Growth | 7.6% | 15.4% | 3.2% | – |
| Gross Profit | $33,635 | $33,094 | $24,193 | $24,638 |
| % Margin | 58.2% | 61.6% | 52% | 54.6% |
| EBITDA | -$1,482 | $3,066 | -$1,626 | -$1,150 |
| % Margin | -2.6% | 5.7% | -3.5% | -2.5% |
| Net Income | -$3,351 | -$106 | -$5,895 | -$6,347 |
| % Margin | -5.8% | -0.2% | -12.7% | -14.1% |
| EPS Diluted | -0.016 | -0.001 | -0.049 | -0.053 |
| % Growth | -1,644.4% | 98.2% | 7% | – |
| Operating Cash Flow | $3,707 | $4,076 | -$1,759 | -$4,574 |
| Capital Expenditures | -$1,775 | -$646 | -$862 | -$2,207 |
| Free Cash Flow | $1,932 | $3,430 | -$2,621 | -$6,782 |